Effects of eythropoietin administration on mitral regurgitation and left ventricular remodeling in heart failure patients.

Cosyns, Bernard; Velez-Roa, S.; Droogmans, S.; Pierard, Luc; Lancellotti, Patrizio

doi:10.1016/j.ijcard.2008.06.064

Article (Scientific journals)

Effects of eythropoietin administration on mitral regurgitation and left ventricular remodeling in heart failure patients.

Cosyns, Bernard; Velez-Roa, S.; Droogmans, S. et al.

2010 • In International Journal of Cardiology, 138 (3), p. 306-307

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/98795

DOI
10.1016/j.ijcard.2008.06.064

PubMed
18760492

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

Cosyns, Int J Cardiol, 2010.pdf

Publisher postprint (47.15 kB)

Download

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Abstract :

[en] The effects of erythropoietin administration on mitral regurgitation in patients with congestive heart failure have not yet been examined. After 2 months, erythropoietin treatment results in a significant reduction in left ventricular volumes and mitral regurgitation severity and improves hemodynamics.

Disciplines :

General & internal medicine

Author, co-author :

Cosyns, Bernard

Velez-Roa, S.

Droogmans, S.

Pierard, Luc ; Université de Liège - ULiège > Département des sciences cliniques > Cardiologie - Pathologie spéciale et réhabilitation

Lancellotti, Patrizio ; Université de Liège - ULiège > Département des sciences cliniques > Imagerie cardiaque fonctionnelle par échographie

Language :

English

Title :

Effects of eythropoietin administration on mitral regurgitation and left ventricular remodeling in heart failure patients.

Publication date :

04 February 2010

Journal title :

International Journal of Cardiology

ISSN :

0167-5273

eISSN :

1874-1754

Publisher :

Elsevier, Amsterdam, Netherlands

Volume :

138

Issue :

Pages :

306-307

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 15 September 2011

Statistics

Number of views

60 (5 by ULiège)

Number of downloads

254 (3 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

OpenAlex citations

Bibliography

Ezekowitz J.A., McAlister F.A., and Armstrong P.W. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure. Circulation 107 (2003) 223-225
Al-Ahmad A., Rand W.M., Manjunath G., et al. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol 38 (2001) 955-962
Silverberg D.S., Wexler D., Blum M., et al. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. J Am Coll Cardiol 35 (2000) 1737-1744
Palazzuoli A., Silverberg D.S., Iovine F., et al. Effects of beta-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with the cardiorenal anemia syndrome. Am Heart J 154 645 (2007) e9-e15
Yoran C., Yellin E.L., Becker R.M., Gabbay S., Frater R.W., and Sonnenblick E.H. Dynamic aspects of acute mitral regurgitation: effects of ventricular volume, pressure and contractility on the effective regurgitant orifice area. Circulation 60 (1979) 170-176
Coats A.J. Ethical authorship and publishing. Int J Cardiol 131 (2009) 149-150